Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2670
Gene Symbol: GFAP
GFAP
0.010 Biomarker disease BEFREE We found that numbers of cells immunolabelled for HLA-DR, GFAP, C5aR, C1q and C3b were increased in WM lesions (WML) and GM lesions (GML) compared to normal appearing WM (NAWM) and GM (NAGM), respectively. 28707765 2018
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.010 Biomarker disease BEFREE Diabetic ketoacidosis as a rare complication of GH therapy emphasizes the importance of screening for carbohydrate intolerance before and during GH treatment in patients with Prader-Willi syndrome. 15112913 2004
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.010 Biomarker disease BEFREE A novel double inversion recovery sequence that suppresses CSF and GM signal was used (GM-double inversion recovery). 29700044 2018
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.010 Biomarker disease BEFREE The frequency of the immunoglobulin heavy chain allotype Glm(2) on chromosome 14 was increased in patients with RA but only in those with the phenotype Gm1,2,3,17;21,5; no significant associations were found between MHC genes and Gm phenotypes. 2111124 1990
Entrez Id: 728
Gene Symbol: C5AR1
C5AR1
0.010 Biomarker disease BEFREE We found that numbers of cells immunolabelled for HLA-DR, GFAP, C5aR, C1q and C3b were increased in WM lesions (WML) and GM lesions (GML) compared to normal appearing WM (NAWM) and GM (NAGM), respectively. 28707765 2018
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.010 Biomarker disease BEFREE Further studies are needed to confirm our proposal that the p53 status of GM tumors can be used to guide our choice of fractionation schemes. 10030268 1999
Entrez Id: 28
Gene Symbol: ABO
ABO
0.010 Biomarker disease BEFREE The frequency of ABO blood groups, Rhesus blood groups, and Gm phenotypes was similar to that in control subjects. 6933131 1980
Entrez Id: 5265
Gene Symbol: SERPINA1
SERPINA1
0.010 Biomarker disease BEFREE In 41 B27+ AAU patients with AS the alpha 1-antitrypsin and Gm phenotype and allotype frequencies were not statistically different from those in B27+ AS patients developing AAU and in B27+ AAU patients without AS, in B27+ AS patients without AAU, B27+ patients with Reiter's syndrome, B27+ patients with low back pain, B27- AAU patients and normal controls. 3498603 1987
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2
0.010 Biomarker disease BEFREE A novel double inversion recovery sequence that suppresses CSF and GM signal was used (GM-double inversion recovery). 29700044 2018
Entrez Id: 3087
Gene Symbol: HHEX
HHEX
0.010 Biomarker disease BEFREE HHEX and PROX1 play significant roles in carbohydrate intolerance and diabetes because these transcription factors may be involved in the regulation of insulin secretion and in glucose and lipid metabolism. 27684496 2017
Entrez Id: 5629
Gene Symbol: PROX1
PROX1
0.010 Biomarker disease BEFREE HHEX and PROX1 play significant roles in carbohydrate intolerance and diabetes because these transcription factors may be involved in the regulation of insulin secretion and in glucose and lipid metabolism. 27684496 2017
Entrez Id: 1378
Gene Symbol: CR1
CR1
0.010 Biomarker disease BEFREE The complement regulators C1INH, CR1, FH and clusterin were more abundant in WM lesions, while the number of C1q+ neurons were increased and the number of C1INH+, clusterin+, FH+ and CR1+ neurons decreased in GM lesions. 28707765 2018
Entrez Id: 55503
Gene Symbol: TRPV6
TRPV6
0.010 Biomarker disease BEFREE We hypothesize that the upregulation of epithelial calcium channels (TRPV6) and 1,25(OH)2D3 are possible factors involved in the pathophysiology of nephrocalcinosis sometimes seen in GGM. 28152538 2017
Entrez Id: 6523
Gene Symbol: SLC5A1
SLC5A1
0.800 AlteredExpression disease BEFREE It also considers congenital defects of sugar metabolism caused by aberrant expression of the SGLT1 in glucose-galactose malabsorption and the SGLT2 in familial renal glycosuria. 21049241 2010
Entrez Id: 6524
Gene Symbol: SLC5A2
SLC5A2
0.020 AlteredExpression disease BEFREE It also considers congenital defects of sugar metabolism caused by aberrant expression of the SGLT1 in glucose-galactose malabsorption and the SGLT2 in familial renal glycosuria. 21049241 2010
Entrez Id: 10563
Gene Symbol: CXCL13
CXCL13
0.010 AlteredExpression disease BEFREE The gCTh was significantly lower in patients with higher CSF CXCL13 levels (2.41 ± 0.1 vs 2.49 ± 0.1 mm, p < 0.05), while no difference in MRI parameters of WM and GM pathology was observed between IgGOB+ and IgGOB-. 28095856 2017
Entrez Id: 929
Gene Symbol: CD14
CD14
0.010 AlteredExpression disease BEFREE Interestingly, AML-193 cells induced with D3 and RA displayed a typical neutrophilic morphology while exhibiting properties specific to monocytic cells, e.g., high expression of CD14 membrane antigen, capacity to bind bacterial lipopolysaccharide, and monocytic-specific esterase activity; this hybrid granulomonocytic (GM) phenotype was not observed upon initial incubation with one inducer and later addition of the other. 7647032 1995
Entrez Id: 3929
Gene Symbol: LBP
LBP
0.010 AlteredExpression disease BEFREE In addition, GGM significantly increased the levels of butyric acid and caproic acid, and reduced the levels of LBP in serum. 30256506 2019
Entrez Id: 6523
Gene Symbol: SLC5A1
SLC5A1
0.800 CausalMutation disease CLINVAR
Entrez Id: 6523
Gene Symbol: SLC5A1
SLC5A1
0.800 GermlineCausalMutation disease ORPHANET Previously we showed that two sisters with GGM had a missense mutation in the SGLT1 gene. 8563765 1996
Entrez Id: 6523
Gene Symbol: SLC5A1
SLC5A1
0.800 GermlineCausalMutation disease ORPHANET Our goal is to determine whether or not mutations in the sodium-glucose cotransporter gene (SGLT1) are responsible for GGM. 12139397 2002